ImThera gets EU approval for sleep apnea device trial

10/5/2009 | San Diego Business Journal

ImThera Medical received approval from the EU to conduct in early 2010 a 12-patient study of a device designed to treat obstructive sleep apnea. Called aura6000, the system uses implantable electrodes that electrically stimulate tongue muscles to keep the tongue from blocking the upper airway.

View Full Article in:

San Diego Business Journal

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Active Implantable Medical Device (AIMD) Product Expert
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Finance Manager - ENT
Jacksonville, FL
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA